➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: May 30, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Dimethicone

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Dimethicone?

Dimethicone is an investigational drug.

There have been 5 clinical trials for Dimethicone. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2009.

The most common disease conditions in clinical trials are Radiodermatitis, Dermatitis, and Psoriasis. The leading clinical trial sponsors are University of British Columbia, G. Pohl-Boskamp GmbH & Co. KG, and Universitätsklinikum Hamburg-Eppendorf.

Recent Clinical Trials for Dimethicone
Topical Menthol +/- Mannitol for Painful Diabetic Peripheral NeuropathyUniversity of British ColumbiaPhase 1/Phase 2
Topical Use of Difinsa53™ to Prevent Radiation DermatitisPoudre Valley Health SystemPhase 1/Phase 2
Topical Use of Difinsa53™ to Prevent Radiation DermatitisProTechSure Scientific, Inc.Phase 1/Phase 2

See all Dimethicone clinical trials

Clinical Trial Summary for Dimethicone

Top disease conditions for Dimethicone
Top clinical trial sponsors for Dimethicone

See all Dimethicone clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.